AR201193A1 - Procedimiento para la preparacion de una vacuna compatible por via intravenosa contra moquillo y hepatitis contagiosa canis - Google Patents

Procedimiento para la preparacion de una vacuna compatible por via intravenosa contra moquillo y hepatitis contagiosa canis

Info

Publication number
AR201193A1
AR201193A1 AR248179A AR24817973A AR201193A1 AR 201193 A1 AR201193 A1 AR 201193A1 AR 248179 A AR248179 A AR 248179A AR 24817973 A AR24817973 A AR 24817973A AR 201193 A1 AR201193 A1 AR 201193A1
Authority
AR
Argentina
Prior art keywords
dole
canis
procedure
preparation
intravenous route
Prior art date
Application number
AR248179A
Other languages
English (en)
Spanish (es)
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Application granted granted Critical
Publication of AR201193A1 publication Critical patent/AR201193A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/175—Canine distemper virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • G—PHYSICS
    • G10—MUSICAL INSTRUMENTS; ACOUSTICS
    • G10L—SPEECH ANALYSIS TECHNIQUES OR SPEECH SYNTHESIS; SPEECH RECOGNITION; SPEECH OR VOICE PROCESSING TECHNIQUES; SPEECH OR AUDIO CODING OR DECODING
    • G10L15/00—Speech recognition
    • G10L15/22—Procedures used during a speech recognition process, e.g. man-machine dialogue
    • G10L2015/226—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics
    • G10L2015/227—Procedures used during a speech recognition process, e.g. man-machine dialogue using non-speech characteristics of the speaker; Human-factor methodology
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/818—Viral vaccine for canidae or mustelidae, e.g. dogs, foxes, minks

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AR248179A 1972-05-26 1973-05-23 Procedimiento para la preparacion de una vacuna compatible por via intravenosa contra moquillo y hepatitis contagiosa canis AR201193A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2225548A DE2225548C3 (de) 1972-05-26 1972-05-26 Intravenös verträglicher Impfstoff gegen Staupe- und Hepatite contagiosa canis

Publications (1)

Publication Number Publication Date
AR201193A1 true AR201193A1 (es) 1975-02-21

Family

ID=5845894

Family Applications (1)

Application Number Title Priority Date Filing Date
AR248179A AR201193A1 (es) 1972-05-26 1973-05-23 Procedimiento para la preparacion de una vacuna compatible por via intravenosa contra moquillo y hepatitis contagiosa canis

Country Status (13)

Country Link
US (1) US3886270A (OSRAM)
AR (1) AR201193A1 (OSRAM)
AT (1) AT336779B (OSRAM)
AU (1) AU467451B2 (OSRAM)
BE (1) BE800132A (OSRAM)
CA (1) CA1020461A (OSRAM)
DE (1) DE2225548C3 (OSRAM)
DK (1) DK141055C (OSRAM)
FR (1) FR2189023B1 (OSRAM)
GB (1) GB1437006A (OSRAM)
NL (1) NL163428C (OSRAM)
SE (1) SE7608007L (OSRAM)
ZA (1) ZA733571B (OSRAM)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL133476B1 (en) * 1981-06-10 1985-06-29 Akad Medyczna Method of obtaining pure antigen hba from human serum
US5000951A (en) * 1987-03-09 1991-03-19 Diamond Scientific Company Multivalent canine distemper virus vaccine
US4990367A (en) * 1987-03-09 1991-02-05 Diamond Scientific Company Canine distemper virus vaccine
CN105884889A (zh) * 2016-04-18 2016-08-24 内蒙古神元生物工程股份有限公司 犬瘟热-传染性肝炎-细小病毒三联卵黄抗体及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3470294A (en) * 1961-06-21 1969-09-30 Behringwerke Ag Vaccine for immunization of dogs and foxes against distemper,hepatitis contagiosa and leptospirosis and process for preparing it
US3316153A (en) * 1965-03-29 1967-04-25 Lilly Co Eli Virus purification
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
US3886270A (en) 1975-05-27
DK141055C (da) 1980-06-23
CA1020461A (en) 1977-11-08
AT336779B (de) 1977-05-25
BE800132A (fr) 1973-11-28
DE2225548B2 (de) 1979-09-06
NL163428C (nl) 1980-09-15
SE7608007L (sv) 1976-07-13
DE2225548A1 (de) 1973-12-06
ATA459273A (de) 1976-09-15
NL7306986A (OSRAM) 1973-11-28
DE2225548C3 (de) 1980-05-29
NL163428B (nl) 1980-04-15
DK141055B (da) 1979-12-31
GB1437006A (en) 1976-05-26
ZA733571B (en) 1974-04-24
AU5612573A (en) 1974-11-28
AU467451B2 (en) 1975-12-04
FR2189023A1 (OSRAM) 1974-01-25
FR2189023B1 (OSRAM) 1976-12-03

Similar Documents

Publication Publication Date Title
DK132303C (da) Fremgangsmade til fremstilling af en legemiddelform med retarderende virkning
AR195041A1 (es) Procedimiento de preparacion de albumina purificada por termocoagulacion
AR222624A1 (es) Procedimiento para la preparacion de una formulacion farmaceutica de liberacion prolongada
ES490210A0 (es) Un procedimiento par la preparacion de una vacuna de la gri-pe.
RO66069A (ro) Procedeu pentru prepararea acizilor 1-oxo-2,2-disubstituiti-5-indaniloxi(sau tio)alcanoici
DK146623C (da) Fremgangsmaade til fremstilling af bifunktionelt tvaerbundet insulin
DK132738C (da) Fremgangsmade til fremstilling af orale penicillinpreparater med forbedret smag
DK154899C (da) Analogifremgangsmaade til fremstilling af aroyl-substituerede phenyleddikesyrederivater.
AR201193A1 (es) Procedimiento para la preparacion de una vacuna compatible por via intravenosa contra moquillo y hepatitis contagiosa canis
MX4221E (es) Procedimiento para la preparacion de una vacuna contra la hidrofobia
SE380524B (sv) Forfarande for framstellning av 2-(alfa-(3-trifluormetyl-fenoxi)-4-klorbensyl)-2-oxazolin
DK139966C (da) Fremgangsmaade til fremstilling af 1-hydroxy-2-pyridoner
AR211914A1 (es) Procedimiento de preparacion de una nueva(diciclopropilmetil-2-aminotizolina
DK145878C (da) Analogifremgangsmaade til fremstilling af alkylthiocyclopentanderivater
IT1059944B (it) Procedimento per l estrazione di una sostanza dolce
IT986561B (it) Procedimento per la preparazione dei trans crisantemo monocarbossi lati alchilici
AR210453A1 (es) Procedimiento para la preparacion de una 6-alfa-dioxitetraciclina
AR204986A1 (es) Procedimiento para la preparacion de derivados de 2-(4-pirolidin-1-iletoxi)anilinobenzotiazol
DK136062C (da) Fremgangsmade til fremstilling af 2-alkylamino-dihydropyridiner
IT7868892A0 (it) Procedimento per la preparazione di microcapsule contenenti una sostanza farmaceutica
MX3789E (es) Procedemiento para la preparacion de una aleacion dental
DK134782C (da) Fremgangsmade til fremstilling af 3beta-hydroxy-5beta-h-steroider
DK133004C (da) Analogifremgangsmade til fremstilling af racemiske eller optisk aktive benzomorphanderivater eller salte deraf
IT1006287B (it) Procedimento per la preparazione di una composizione di nerofumo
AR197158A1 (es) Procedimiento para la preparacion de una vacuna oral contra la gastroenteritis trasmisible porcina